0.634
Xtant Medical Holdings Inc stock is traded at $0.634, with a volume of 412.98K.
It is up +7.53% in the last 24 hours and up +8.93% over the past month.
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as could be used in conjunction with a hardware plate system. The company also provides OsteoSTX for posterolateral spine surgery applications, including scoliosis procedures; and 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers various products to treat a range of spinal and sacroiliac conditions, including trauma, degeneration, deformity, and tumor. Xtant Medical Holdings, Inc. markets its products through direct sales, consignment agents, reseller distributors, private label distributors, and technology licensees. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
See More
Previous Close:
$0.5896
Open:
$0.5723
24h Volume:
412.98K
Relative Volume:
2.25
Market Cap:
$88.76M
Revenue:
$78.46M
Net Income/Loss:
$2.75M
P/E Ratio:
63.40
EPS:
0.01
Net Cash Flow:
$-12.42M
1W Performance:
+10.30%
1M Performance:
+8.93%
6M Performance:
+3.92%
1Y Performance:
+40.89%
Xtant Medical Holdings Inc Stock (XTNT) Company Profile
Name
Xtant Medical Holdings Inc
Sector
Industry
Phone
406-388-0480
Address
664 Cruiser Lane, Belgrade, MT
Compare XTNT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
XTNT
Xtant Medical Holdings Inc
|
0.634 | 82.55M | 78.46M | 2.75M | -12.42M | 0.01 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
Xtant Medical Holdings Inc Stock (XTNT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-05-23 | Initiated | BTIG Research | Buy |
| Nov-15-18 | Reiterated | Maxim Group | Buy |
| Feb-14-18 | Reiterated | Maxim Group | Buy |
Xtant Medical Holdings Inc Stock (XTNT) Latest News
Xtant Medical Holdings receives USD 10.7M from Companion Spine - Medical Buyer
Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Short Interest Update - MarketBeat
Xtant Medical receives $10.7M payment from Companion Spine By Investing.com - Investing.com Australia
Xtant Medical receives $10.7 million payment from Companion Spine, prepays loan - Investing.com
Xtant Medical receives $10.7 million payment from Companion Spine, prepays loan By Investing.com - Investing.com South Africa
Xtant Medical Boosts Liquidity After Companion Spine Repayment - TipRanks
Xtant Medical finalizes Companion Spine transactions - marketscreener.com
Xtant Medical Holdings receives $10.7M payment, total sale proceeds rise to $21.4M - TradingView
Xtant Medical (NYSE: XTNT) receives $10.7M and pays down debt - Stock Titan
Spine asset sale brings Xtant $21.4M to cut debt, add cash - Stock Titan
Xtant Medical receives $10.7M payment from Companion Spine - Investing.com
Update Report: Is Xtant Medical Holdings Inc stock a value trapTrade Entry Report & AI Enhanced Execution Alerts - baoquankhu1.vn
Stock Analysis: Is Xtant Medical Holdings Inc stock a buy or sell2025 Volatility Report & Safe Capital Allocation Plans - baoquankhu1.vn
Xtant Medical (XTNT) to Release Quarterly Earnings on Thursday - MarketBeat
XTNT Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Xtant Medical to Participate in the Canaccord Genuity 2026 Musculoskeletal Conference - StreetInsider
Xtant CEO, CFO and COO to speak at 2026 Canaccord musculoskeletal conference - Stock Titan
Published on: 2026-02-25 15:00:35 - baoquankhu1.vn
Market Moves: Will Xtant Medical Holdings Inc outperform the market in YEARJuly 2025 Trends & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Buyback Watch: Is Xtant Medical Holdings Inc stock a buy or sell2025 Trading Volume Trends & Stock Portfolio Risk Management - baoquankhu1.vn
What’s next for Xtant Medical Holdings Inc. stockJobs Report & Free Safe Capital Growth Stock Tips - mfd.ru
Moving Averages: Can Xtant Medical Holdings Inc deliver consistent dividendsGDP Growth & Verified Short-Term Plans - baoquankhu1.vn
Lytton, foundation report 5% Xtant Medical (NASDAQ: XTNT) stake - Stock Titan
Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Short Interest Down 16.4% in January - MarketBeat
Rate Cut: Whats next for Xtant Medical Holdings Inc stockJuly 2025 Trade Ideas & Verified Short-Term Plans - baoquankhu1.vn
Is Xtant Medical Holdings Inc. stock a value trapJuly 2025 Snapshot & Comprehensive Market Scan Reports - mfd.ru
What dividend safety rating applies to Xtant Medical Holdings Inc. (XMS) stock2025 Price Targets & Daily Entry Point Alerts - mfd.ru
Is Xtant Medical Holdings Inc. stock a buy in volatile marketsJuly 2025 News Drivers & Scalable Portfolio Growth Methods - mfd.ru
Bond Watch: Can Xtant Medical Holdings Inc. (XMS) stock withstand sector downturnsJuly 2025 Volume & Long Hold Capital Preservation Tips - mfd.ru
Will Xtant Medical Holdings Inc. stock beat Nasdaq index returnsMarket Rally & Expert Approved Momentum Trade Ideas - mfd.ru
Is Xtant Medical Holdings Inc.’s ROIC above industry average2025 Macro Impact & Community Consensus Stock Picks - mfd.ru
Will Xtant Medical Holdings Inc. outperform the market in YEAR2025 Winners & Losers & Free Technical Pattern Based Buy Signals - mfd.ru
Will Xtant Medical Holdings Inc. benefit from seasonalityQuarterly Profit Summary & Free Verified High Yield Trade Plans - mfd.ru
Sentiment Review: Is Xtant Medical Holdings Inc gaining market shareJuly 2025 Big Picture & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Aug Volume: Can Xtant Medical Holdings Inc navigate macro headwindsMarket Weekly Review & AI Driven Stock Movement Reports - baoquankhu1.vn
Investment Report: Can Xtant Medical Holdings Inc deliver consistent dividendsPortfolio Value Summary & Target Return Focused Stock Picks - baoquankhu1.vn
Retail Surge: Is Xtant Medical Holdings Inc stock overvalued or fairly pricedJuly 2025 Short Interest & Expert Curated Trade Setups - baoquankhu1.vn
Trading Recap: Will Xtant Medical Holdings Inc benefit from rising consumer demandWeekly Trade Review & Expert Curated Trade Setups - baoquankhu1.vn
FOMO Trade: Is Xtant Medical Holdings Inc stock overvalued or fairly pricedNew Guidance & Low Risk Entry Point Guides - baoquankhu1.vn
Moving Averages: What hedge funds are buying Xtant Medical Holdings IncInflation Watch & Fast Gaining Stock Reports - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Short Interest Down 25.3% in January - MarketBeat
Bank Watch: Is Xtant Medical Holdings Inc stock a value trapDay Trade & Stepwise Trade Execution Plans - baoquankhu1.vn
Shorts Report: Is Xtant Medical Holdings Inc stock a top performer YTD2025 Historical Comparison & Verified High Yield Trade Plans - baoquankhu1.vn
Published on: 2026-01-27 00:29:06 - baoquankhu1.vn
Xtant Medical Reports Strong Q3 2025 Results - MSN
Xtant Medical (NYSEAMERICAN:XTNT) Share Price Crosses Above 200 Day Moving AverageTime to Sell? - MarketBeat
Volume Summary: Is Xtant Medical Holdings Inc stock a value trapJuly 2025 Retail & Weekly High Return Forecasts - baoquankhu1.vn
US Market Recap: Will Xtant Medical Holdings Inc benefit from government policyJuly 2025 Analyst Calls & Weekly Top Gainers Trade List - baoquankhu1.vn
Xtant Medical Extends Note Maturity After Asset Divestitures - TipRanks
Xtant Medical Extends Note Maturity and Adjusts Payment Timing - TradingView
Xtant Medical Holdings Inc Stock (XTNT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):